Publications by authors named "Rachel Airley"

Claim this Profile
C
Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report.
Jonai Pujol-Gimenez, Fátima Pérez de Heredia, Miguel Angel Idoate, Rachel Airley, María Pilar Lostao

J Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How the science of personalized medicines will change the clinical management of patients in the pharmacy.
Rachel Airley, Andy Evans

Future Med Chem· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers?
Rachel Airley

Future Med Chem· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas.
Monika Golinska, Helen Troy, Yuen-Li Chung, Paul M McSheehy, Manuel Mayr, Rachel E Airley

BMC Cancer· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.
Rachel Airley, Andrew Evans, Ali Mobasheri, Stephen M Hewitt

Ann Anat· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Andrew Evans, Victoria Bates, Helen Troy, Stephen Hewitt, Susan Holbeck, Rachel Airley

Cancer Chemother Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
Rachel E Airley, Ali Mobasheri

Chemotherapy· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
Ali Mobasheri, Rachel Airley, Stephen M Hewitt, David Marples

Int J Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.
Rachel L Cowen, Adam V Patterson, Brian A Telfer, Rachel E Airley, Steve Hobbs

Mol Cancer Ther· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Rachel E Airley, Juliette Loncaster, James A Raleigh, Adrian L Harris, Susan E Davidson

Int J Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis.
Kaye J Williams, Brian A Telfer, Rachel E Airley, Hans P W Peters, Mary R Sheridan

Oncogene· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis